Roux-en-Y Gastric Bypass (RYGB) is a popular form of bariatric surgery that reduces the size of the stomach and reroutes the digestive system. This results in both restriction of food intake and malabsorption, leading to significant weight loss. The surgery is considered highly effective for morbidly obese individuals and also helps improve obesity-related health issues like diabetes, hypertension, and sleep apnea. However, it requires lifelong dietary changes and nutritional supplements to avoid deficiencies.

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

Stomach stapling is an older term for bariatric surgery procedures that reduce stomach size. It involves surgically creating a smaller stomach pouch using staples, which limits food intake. Modern techniques like gastric sleeve surgery have replaced traditional stomach stapling, but the principle remains the same—restricting food capacity.

Roux-en-Y bypass is another term for the RNY procedure. This surgery helps patients lose weight by creating a small pouch from the stomach and connecting it directly to the small intestine, bypassing a portion of the digestive tract. The result is a reduced ability to absorb calories and nutrients. Patients who undergo RNY experience rapid weight loss, but it also requires them to make permanent changes to their diet and lifestyle to avoid complications like dumping syndrome, where food moves too quickly from the... +More